| 1 | Does High Standard Uptake Value on Positron Emission Tomography Preclude Sublobar Resection in Stage IA Non-Small Cell Lung Cancer ≤2 cm? | 2.6 | 2 | Citations (PDF) |
| 2 | Temporal Trends in the Utilization and Survival Outcomes of Lobar, Segmental, and Wedge Resection for Early-Stage NSCLC, 2004 to 2020 | 0.6 | 0 | Citations (PDF) |
| 3 | No down-side to starting durvalumab immediately after chemoradiation for unresectable stage III non-small cell lung cancer—some answers but more questions | 0.9 | 1 | Citations (PDF) |
| 4 | All segments are created equal: locoregional recurrence and survival after single versus multi-segment resection in patients with clinical stage IA ≤2 cm non-small-cell lung cancer | 1.2 | 1 | Citations (PDF) |
| 5 | Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non–Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial | 12.4 | 48 | Citations (PDF) |
| 6 | The extent of lymph node dissection is not associated with disease-free survival following lobar or sublobar resection: Results from Cancer and Leukemia Group B 140503 (Alliance) | 2.2 | 7 | Citations (PDF) |
| 7 | Disparities in adherence to guideline-concordant care and receipt of immunotherapy for Non-Small cell lung cancer in the United States | 1.8 | 7 | Citations (PDF) |
| 8 | Neoadjuvant nonablative stereotactic body radiotherapy plus immunotherapy yields similar pathologic response as chemoimmunotherapy in non–small cell lung cancer | 2.2 | 2 | Citations (PDF) |
| 9 | Sublobar Resection vs Lobectomy for Stage IA Non-Small Cell Lung Carcinoma—Takeaways From Modern Randomized Trials | 2.6 | 10 | Citations (PDF) |
| 10 | A signature of enhanced proliferation associated with response and survival to anti-PD-L1 therapy in early-stage non-small cell lung cancer | 5.3 | 8 | Citations (PDF) |
| 11 | Wedge resection, segmentectomy, and lobectomy: oncologic outcomes based on extent of surgical resection for ≤2 cm stage IA non-small cell lung cancer | 0.9 | 9 | Citations (PDF) |
| 12 | Ultrasensitive plasma-based monitoring of tumor burden using machine-learning-guided signal enrichment | 22.6 | 118 | Citations (PDF) |
| 13 | Deficiency of metabolic regulator PKM2 activates the pentose phosphate pathway and generates TCF1+ progenitor CD8+ T cells to improve immunotherapy | 14.1 | 47 | Citations (PDF) |
| 14 | A robotic-assisted thymectomy is equivalent to a transsternal resection in large thymomas | 0.9 | 6 | Citations (PDF) |
| 15 | Extended Lymphadenectomy Improves Survival After Induction Chemoradiation for Esophageal Cancer | 3.4 | 15 | Citations (PDF) |
| 16 | Surgical resection after neoadjuvant durvalumab and radiation is feasible and safe in non–small cell lung cancer: Results from a randomized trial | 2.2 | 20 | Citations (PDF) |
| 17 | Integration of New Systemic Adjuvant Therapies for Non-small Cell Lung Cancer: Role of the Surgeon | 2.6 | 3 | Citations (PDF) |
| 18 | Tumor-intrinsic IRE1α signaling controls protective immunity in lung cancer | 10.8 | 40 | Citations (PDF) |
| 19 | Regulation of PD-L1 Trafficking from Synthesis to Degradation | 3.1 | 33 | Citations (PDF) |
| 20 | Sub-Lobar Resection: The New Standard of Care for Early-Stage Lung Cancer | 2.7 | 16 | Citations (PDF) |
| 21 | Cancer and Leukemia Group B 140503: Is it time to turn the page on Lung Cancer Study Group 821? | 2.2 | 2 | Citations (PDF) |
| 22 | Should sampling of three N2 stations be a quality metric for curative resection of stage I lung cancer? | 2.2 | 5 | Citations (PDF) |
| 23 | A 20-year Follow-up of the International Early Lung Cancer Action Program (I-ELCAP) | 6.7 | 77 | Citations (PDF) |
| 24 | Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial | 10.8 | 44 | Citations (PDF) |
| 25 | Sublobar resection is comparable to lobectomy for screen-detected lung cancer | 2.2 | 38 | Citations (PDF) |
| 26 | Two-field lymph node dissection or three-field lymph node dissection. What's in a name? | 2.2 | 3 | Citations (PDF) |
| 27 | Outcomes After Surgical Resection of Early-stage Lung Adenocarcinomas With Epidermal Growth Factor Receptor Mutations | 2.6 | 6 | Citations (PDF) |
| 28 | Adjuvant therapy for early-stage non–small cell lung cancer: The breaking of a new dawn | 2.2 | 2 | Citations (PDF) |
| 29 | Extent of Resection Influences Survival in Early-Stage Lung Cancer With Occult Nodal Disease | 2.6 | 22 | Citations (PDF) |
| 30 | Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non–small cell lung cancer | 8.7 | 45 | Citations (PDF) |
| 31 | Safety of lung cancer surgery during COVID-19 in a pandemic epicenter | 2.2 | 16 | Citations (PDF) |
| 32 | Integrative network analysis of early-stage lung adenocarcinoma identifies aurora kinase inhibition as interceptor of invasion and progression | 10.8 | 28 | Citations (PDF) |
| 33 | Global evolution of the tumor microenvironment associated with progression from preinvasive invasive to invasive human lung adenocarcinoma | 4.4 | 44 | Citations (PDF) |
| 34 | Treatment of cT3N1M0/IIIA non–small cell lung cancer and the risk of underuse of surgery | 2.2 | 2 | Citations (PDF) |
| 35 | National trends and perioperative outcomes of robotic oesophagectomy following induction chemoradiation therapy: a National Cancer Database propensity-matched analysis | 1.2 | 5 | Citations (PDF) |
| 36 | Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial | 16.1 | 326 | Citations (PDF) |
| 37 | Validation of a Circulating Tumor DNA-Based Next-Generation Sequencing Assay in a Cohort of Patients with Solid tumors: A Proposed Solution for Decentralized Plasma Testing | 2.5 | 21 | Citations (PDF) |
| 38 | Radiation-activated secretory proteins of Scgb1a1+ club cells increase the efficacy of immune checkpoint blockade in lung cancer | 15.2 | 55 | Citations (PDF) |
| 39 | Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial | 46.9 | 1,377 | Citations (PDF) |
| 40 | Sternal Reconstruction Using Customized 3D-Printed Titanium Implants | 2.6 | 30 | Citations (PDF) |
| 41 | Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring | 22.6 | 397 | Citations (PDF) |
| 42 | Anti-PDL1 effect in squamous non-small cell lung cancer | 1.3 | 2 | Citations (PDF) |
| 43 | Staple Line Thickening After Sublobar Resection: Reaction or Recurrence? | 2.6 | 13 | Citations (PDF) |
| 44 | Do the surgical results in the National Lung Screening Trial reflect modern thoracic surgical practice? | 2.2 | 26 | Citations (PDF) |
| 45 | TOX is a critical regulator of tumour-specific T cell differentiation | 30.7 | 1,079 | Citations (PDF) |
| 46 | Adjuvant Therapy for Node-Positive Esophageal Cancer After Induction and Surgery: A Multisite Study | 2.6 | 38 | Citations (PDF) |
| 47 | Sublobar resection for node-negative lung cancer 2–5 cm in size | 1.2 | 20 | Citations (PDF) |
| 48 | Role of wedge resection in bronchial carcinoid (BC) tumors: SEER database analysis | 0.9 | 12 | Citations (PDF) |
| 49 | National trends and perioperative outcomes of robotic resection of thymic tumours in the United States: a propensity matching comparison with open and video-assisted thoracoscopic approaches† | 1.2 | 37 | Citations (PDF) |
| 50 | Reintervention and Survival After Limited Lung Resection for Lung Cancer Treatment in Australia | 2.6 | 4 | Citations (PDF) |
| 51 | Extent of lymphadenectomy is associated with oncological efficacy of sublobar resection for lung cancer ≤2 cm | 2.2 | 55 | Citations (PDF) |
| 52 | Do individual surgeon volumes affect outcomes in thoracic surgery?† | 1.2 | 21 | Citations (PDF) |
| 53 | Segmentectomy Is Equivalent to Lobectomy in Hypermetabolic Clinical Stage IA Lung Adenocarcinomas | 2.6 | 30 | Citations (PDF) |
| 54 | Neoadjuvant Therapy for Locally Advanced Esophageal Cancer Should Be Targeted to Tumor Histology | 2.6 | 10 | Citations (PDF) |
| 55 | Molecular Testing for Early Lung Cancer | 1.7 | 1 | Citations (PDF) |
| 56 | Predictors of Survival After Treatment of Oligometastases After Esophagectomy | 2.6 | 42 | Citations (PDF) |
| 57 | Are minimum volume standards appropriate for lung and esophageal surgery? | 2.2 | 34 | Citations (PDF) |
| 58 | T1N0 oesophageal cancer: patterns of care and outcomes over 25 years† | 1.2 | 12 | Citations (PDF) |
| 59 | Pulmonary sarcomatoid carcinoma: an analysis of a rare cancer from the Surveillance, Epidemiology, and End Results database† | 1.2 | 58 | Citations (PDF) |
| 60 | Never smokers with resected lung cancer: different demographics, similar survival† | 1.2 | 21 | Citations (PDF) |
| 61 | Immune reprogramming via PD-1 inhibition enhances early-stage lung cancer survival | 3.7 | 59 | Citations (PDF) |
| 62 | What is the role of wedge resection for T1a lung cancer? | 0.9 | 9 | Citations (PDF) |
| 63 | Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503) | 15.9 | 363 | Citations (PDF) |
| 64 | Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis | 2.6 | 41 | Citations (PDF) |
| 65 | Incidence and Prognostic Significance of Carcinoid Lymph Node Metastases | 2.6 | 61 | Citations (PDF) |
| 66 | The lung microenvironment: an important regulator of tumour growth and metastasis | 34.5 | 1,074 | Citations (PDF) |
| 67 | Matrix Metalloproteinase 14 promotes lung cancer by cleavage of Heparin-Binding EGF-like Growth Factor | 2.7 | 56 | Citations (PDF) |
| 68 | Robotic Thymectomy: Learning Curve and Associated Perioperative Outcomes | 0.7 | 35 | Citations (PDF) |
| 69 | The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein | 3.6 | 44 | Citations (PDF) |
| 70 | Clinical Predictors of Nodal Metastases in Peripherally Clinical T1a N0 Non-Small Cell Lung Cancer | 2.6 | 48 | Citations (PDF) |
| 71 | Biopsy first: Lessons learned from Cancer and Leukemia Group B (CALGB) 140503 | 2.2 | 80 | Citations (PDF) |
| 72 | PUB010 Intraoperative Blood Loss is an Independent Predictor of Poor Disease Free Survival for Patients Undergoing VATS Lobectomy for Lung Cancer | 1.5 | 0 | Citations (PDF) |
| 73 | Video-Assisted Thoracoscopic Lobectomy Is the Preferred Approach Following Induction Chemotherapy | 0.7 | 37 | Citations (PDF) |
| 74 | Robotic Thymectomy Is Feasible for Large Thymomas: A Propensity-Matched Comparison | 2.6 | 73 | Citations (PDF) |
| 75 | Phase I Study of Epigenetic Priming with Azacitidine Prior to Standard Neoadjuvant Chemotherapy for Patients with Resectable Gastric and Esophageal Adenocarcinoma: Evidence of Tumor Hypomethylation as an Indicator of Major Histopathologic Response | 4.5 | 67 | Citations (PDF) |
| 76 | Clinical Predictors of Persistent Mediastinal Nodal Disease After Induction Therapy for Stage IIIA N2 Non-Small Cell Lung Cancer | 2.6 | 14 | Citations (PDF) |
| 77 | Variation by stage in the effects of prediagnosis weight loss on mortality in a prospective cohort of esophageal cancer patients | 0.6 | 20 | Citations (PDF) |
| 78 | The NeoRes trial: questioning the benefit of radiation therapy as part of neoadjuvant therapy for esophageal adenocarcinoma | 0.9 | 7 | Citations (PDF) |
| 79 | O-087VIDEO-ASSISTED THORACOSCOPIC LOBECTOMY IS THE PREFERRED APPROACH FOLLOWING INDUCTION CHEMOTHERAPY | 0.8 | 0 | Citations (PDF) |
| 80 | Adenovirus Protein E4-ORF1 Activation of PI3 Kinase Reveals Differential Regulation of Downstream Effector Pathways in Adipocytes | 4.4 | 17 | Citations (PDF) |
| 81 | Variability in length of stay after uncomplicated pulmonary lobectomy: is length of stay a quality metric or a patient metric? | 1.2 | 53 | Citations (PDF) |
| 82 | Incidence and implications of postoperative supraventricular tachycardia after pulmonary lobectomy | 2.2 | 28 | Citations (PDF) |
| 83 | Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial | 16.1 | 490 | Citations (PDF) |
| 84 | Predictors of Pleural Implants in Patients With Thymic Tumors | 2.6 | 12 | Citations (PDF) |
| 85 | Anatomical Segmentectomy and Wedge Resections Are Associated with Comparable Outcomes for Patients with Small cT1N0 Non–Small Cell Lung Cancer | 1.5 | 138 | Citations (PDF) |
| 86 | Prediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients | 2.0 | 10 | Citations (PDF) |
| 87 | Screening for Lung Cancer | 0.8 | 13 | Citations (PDF) |
| 88 | Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery: Effects of Cumulative Institutional Experience on Adequacy of Lymphadenectomy | 2.6 | 53 | Citations (PDF) |
| 89 | Locally advanced esophageal cancer: What becomes of 5-year survivors? | 2.2 | 22 | Citations (PDF) |
| 90 | Video-Assisted Thoracoscopic Surgery Is a Safe and Effective Alternative to Thoracotomy for Anatomical Segmentectomy in Patients With Clinical Stage I Non-Small Cell Lung Cancer | 2.6 | 93 | Citations (PDF) |
| 91 | Preoperative Chemoradiation Therapy Versus Chemotherapy in Patients Undergoing Modified En Bloc Esophagectomy for Locally Advanced Esophageal Adenocarcinoma: Is Radiotherapy Beneficial? | 2.6 | 35 | Citations (PDF) |
| 92 | Incidence and Factors Associated With Hospital Readmission After Pulmonary Lobectomy | 2.6 | 34 | Citations (PDF) |
| 93 | Predictors of Disease-free Survival and Recurrence in Patients with Resected Bronchial Carcinoid Tumors | 0.3 | 16 | Citations (PDF) |
| 94 | Extended resection of sarcomas involving the mediastinum: a 15-year experience | 1.2 | 14 | Citations (PDF) |
| 95 | Identification of Reprogrammed Myeloid Cell Transcriptomes in NSCLC | 1.5 | 17 | Citations (PDF) |
| 96 | Sternal Resections: New Materials for Reconstruction | 0.6 | 9 | Citations (PDF) |
| 97 | Lung inflammation promotes metastasis through neutrophil protease-mediated degradation of Tsp-1 | 5.2 | 202 | Citations (PDF) |
| 98 | Clinical predictors of early cancer-related mortality following neoadjuvant therapy and oesophagectomy† | 1.2 | 21 | Citations (PDF) |
| 99 | Transcriptome Analysis of Individual Stromal Cell Populations Identifies Stroma-Tumor Crosstalk in Mouse Lung Cancer Model | 4.4 | 188 | Citations (PDF) |
| 100 | Computed Tomography Screening | 1.1 | 14 | Citations (PDF) |
| 101 | Perioperative Outcomes after Lung Resection in Obese Patients | 0.3 | 10 | Citations (PDF) |
| 102 | National Analysis of Short-Term Outcomes After Pulmonary Resections on Cardiopulmonary Bypass | 2.6 | 4 | Citations (PDF) |
| 103 | Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance | 30.7 | 1,699 | Citations (PDF) |
| 104 | Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small cell lung cancer | 2.2 | 21 | Citations (PDF) |
| 105 | Long term survival with thoracoscopic versus open lobectomy: propensity matched comparative analysis using SEER-Medicare database | 0.2 | 120 | Citations (PDF) |
| 106 | Outcomes in the management of esophageal cancer | 1.2 | 78 | Citations (PDF) |
| 107 | Outcomes of Unresected Ground-Glass Nodules with Cytology Suspicious for Adenocarcinoma | 1.5 | 32 | Citations (PDF) |
| 108 | Balancing curability and unnecessary surgery in the context of computed tomography screening for lung cancer | 2.2 | 61 | Citations (PDF) |
| 109 | A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer | 2.6 | 53 | Citations (PDF) |
| 110 | Surgical Lung Biopsy in Adult Respiratory Distress Syndrome: A Meta-Analysis | 2.6 | 49 | Citations (PDF) |
| 111 | Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules | 2.2 | 317 | Citations (PDF) |
| 112 | Comparative Effectiveness of Robotic-Assisted vs Thoracoscopic LobectomyChest, 2014, 146, 1505-1512 | 0.8 | 133 | Citations (PDF) |
| 113 | Ratio of Positron Emission Tomography Uptake to Tumor Size in Surgically Resected Non–Small Cell Lung Cancer | 2.6 | 29 | Citations (PDF) |
| 114 | Inaugural Discussions in Cardiothoracic Treatment and Care: Surgery for Esophageal Cancer, November 16, 2012, Boston, MA | 1.3 | 1 | Citations (PDF) |
| 115 | Induction Therapy for Esophageal Cancer | 1.1 | 5 | Citations (PDF) |
| 116 | Cancer-testis gene expression is associated with the methylenetetrahydrofolate reductase 677 C>T polymorphism in non-small cell lung carcinoma | 1.8 | 5 | Citations (PDF) |
| 117 | Complete Metabolic Response Is Not Uniformly Predictive of Complete Pathologic Response After Induction Therapy for Esophageal Cancer | 2.6 | 14 | Citations (PDF) |
| 118 | Prevalence and Outcomes of Anatomic Lung Resection for Hemoptysis: An Analysis of the Nationwide Inpatient Sample Database | 2.6 | 15 | Citations (PDF) |
| 119 | Long-Term Survival After Lobectomy for Non-Small Cell Lung Cancer by Video-Assisted Thoracic Surgery Versus Thoracotomy | 2.6 | 141 | Citations (PDF) |
| 120 | Outcomes of Lobectomy in Patients with Severely Compromised Lung Function (Predicted Postoperative Diffusing Capacity of the Lung for Carbon Monoxide % ≤ 40%) | 2.1 | 19 | Citations (PDF) |
| 121 | Management and Outcomes of Patients on Preoperative Plavix (Clopidogrel) Undergoing General Thoracic Surgery | 0.3 | 10 | Citations (PDF) |
| 122 | Outcomes after lobectomy using thoracoscopy vs thoracotomy: a comparative effectiveness analysis utilizing the Nationwide Inpatient Sample database | 1.2 | 215 | Citations (PDF) |
| 123 | Localized mesothelioma tumour arising synchronously with a primary contralateral lung cancer: Figure 1: | 0.8 | 9 | Citations (PDF) |
| 124 | Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy | 1.2 | 51 | Citations (PDF) |
| 125 | Comparative Analysis of Diaphragmatic Hernia Repair Outcomes Using the Nationwide Inpatient Sample Database | 2.4 | 35 | Citations (PDF) |
| 126 | Radiographic and Clinical Characterization of False Negative Results from CT-Guided Needle Biopsies of Lung Nodules | 1.5 | 54 | Citations (PDF) |
| 127 | Definitive Therapy for Isolated Esophageal Metastases Prolongs Survival | 2.6 | 11 | Citations (PDF) |
| 128 | Traditional Techniques of Esophagectomy | 1.2 | 18 | Citations (PDF) |
| 129 | Gastropericardial Fistula: A Late Complication of Esophageal Reconstruction | 2.6 | 11 | Citations (PDF) |
| 130 | Screening for Lung Cancer: Challenges for the Thoracic Surgeon | 0.8 | 6 | Citations (PDF) |
| 131 | Preoperative Taxane-Based Chemotherapy and Celecoxib for Carcinoma of the Esophagus and Gastroesophageal Junction: Results of a Phase 2 Trial | 1.5 | 21 | Citations (PDF) |
| 132 | Survival of patients with clinical stage IIIA non–small cell lung cancer after induction therapy: Age, mediastinal downstaging, and extent of pulmonary resection as independent predictors | 2.2 | 57 | Citations (PDF) |
| 133 | Predictors of recurrence and disease-free survival in patients with completely resected esophageal carcinoma | 2.2 | 52 | Citations (PDF) |
| 134 | Prevalence, outcomes, and a risk–benefit analysis of diaphragmatic hernia admissions: An examination of the National Inpatient Sample database | 2.2 | 12 | Citations (PDF) |
| 135 | Cumulative Radiation Dose From Medical Imaging Procedures in Patients Undergoing Resection for Lung Cancer | 2.6 | 17 | Citations (PDF) |
| 136 | Clinical T2-T3N0M0 Esophageal Cancer: The Risk of Node Positive Disease | 2.6 | 92 | Citations (PDF) |
| 137 | Lobectomy in Octogenarians With Non-Small Cell Lung Cancer: Ramifications of Increasing Life Expectancy and the Benefits of Minimally Invasive Surgery | 2.6 | 108 | Citations (PDF) |
| 138 | Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer | 1.7 | 326 | Citations (PDF) |
| 139 | Analysis of Spontaneous Vs. Vaccine-Induced Antibody Responses Against Cancer-Testis Antigen MAGE-A3 in Cancer PatientsBlood, 2011, 118, 5087-5087 | 3.6 | 0 | Citations (PDF) |
| 140 | Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: A propensity-matched analysis from the STS database | 2.2 | 780 | Citations (PDF) |
| 141 | Predictors of survival in patients with persistent nodal metastases after preoperative chemotherapy for esophageal cancer | 2.2 | 25 | Citations (PDF) |
| 142 | Predictors of Cervical and Recurrent Laryngeal Lymph Node Metastases From Esophageal Cancer | 2.6 | 26 | Citations (PDF) |
| 143 | T1644 Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of PostOperative Disease Recurrence in Esophageal Cancer | 0.9 | 0 | Citations (PDF) |
| 144 | Use of Amplatzer device for endobronchial closure of bronchopleural fistulas | 0.8 | 30 | Citations (PDF) |
| 145 | In Situ Evidence of KRAS Amplification and Association With Increased p21 Levels in Non–Small Cell Lung Carcinoma | 0.4 | 24 | Citations (PDF) |
| 146 | POINT: Clinical stage IA non–small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non–small cell lung cancer: The problem of understaging | 2.2 | 67 | Citations (PDF) |
| 147 | Bone marrow-derived endothelial progenitor cells contribute to the angiogenic switch in tumor growth and metastatic progression | 5.8 | 105 | Citations (PDF) |
| 148 | Partial Upper Sternotomy for Anterosuperior Mediastinal Surgery: An Institutional Experience | 1.7 | 12 | Citations (PDF) |
| 149 | A Case of Severe Heartburn | 2.6 | 1 | Citations (PDF) |
| 150 | Invited Commentary | 2.6 | 0 | Citations (PDF) |
| 151 | TNM Stage Is the Most Important Determinant of Survival in Metachronous Lung Cancer | 2.6 | 47 | Citations (PDF) |
| 152 | Predictors of Long-Term Survival After Resection of Esophageal Carcinoma With Nonregional Nodal Metastases | 2.6 | 49 | Citations (PDF) |
| 153 | Hernia of Morgagni: Case report | 2.2 | 9 | Citations (PDF) |
| 154 | Primary esophageal large T-cell lymphoma mimicking esophageal carcinoma: A case report and literature review | 2.2 | 9 | Citations (PDF) |
| 155 | Carcinoid tumor nested within a bronchogenic cyst | 2.2 | 15 | Citations (PDF) |
| 156 | Detection of lung cancer using weighted digital analysis of breath biomarkers | 0.7 | 223 | Citations (PDF) |
| 157 | Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming | 5.2 | 157 | Citations (PDF) |
| 158 | Total Number of Resected Lymph Nodes Predicts Survival in Esophageal Cancer | 3.4 | 277 | Citations (PDF) |
| 159 | Multifocal Neoplasia and Nodal Metastases in T1 Esophageal Carcinoma | 3.4 | 88 | Citations (PDF) |
| 160 | Predicting Systemic Disease in Patients With Esophageal Cancer After Esophagectomy | 3.4 | 292 | Citations (PDF) |
| 161 | Prediction of lung cancer using volatile biomarkers in breath1 | 0.7 | 297 | Citations (PDF) |
| 162 | Surgical Resection for Multifocal (T4) Non-Small Cell Lung Cancer: Is the T4 Designation Valid? | 2.6 | 41 | Citations (PDF) |
| 163 | Risk Factors for Occult Mediastinal Metastases in Clinical Stage I Non-Small Cell Lung Cancer | 2.6 | 220 | Citations (PDF) |
| 164 | Positron Emission Tomographic Scanning Predicts Survival After Induction Chemotherapy for Esophageal Carcinoma | 2.6 | 68 | Citations (PDF) |
| 165 | The Role of CT Screening for Lung Cancer | 1.1 | 12 | Citations (PDF) |
| 166 | Giant cavernous hemangioma of the distal esophagus treated with esophagectomy | 2.2 | 7 | Citations (PDF) |
| 167 | Accuracy of Surveillance Computed Tomography in Detecting Recurrent or New Primary Lung Cancer in Patients With Completely Resected Lung Cancer | 2.6 | 40 | Citations (PDF) |
| 168 | Downstaging of T or N Predicts Long-Term Survival After Preoperative Chemotherapy and Radical Resection for Esophageal Carcinoma | 2.6 | 47 | Citations (PDF) |
| 169 | Reply to the Editor | 2.2 | 2 | Citations (PDF) |
| 170 | Long-term survival and recurrence in patients with resected non–small cell lung cancer 1 cm or less in size | 2.2 | 35 | Citations (PDF) |
| 171 | Randomized Phase II Trial of Docetaxel/Irinotecan and Gemcitabine/Irinotecan With or Without Celecoxib in the Second-Line Treatment of Non–Small-Cell Lung Cancer | 12.4 | 61 | Citations (PDF) |
| 172 | Tumor Size Is a Determinant of Stage Distribution in T1 Non-Small Cell Lung CancerChest, 2005, 128, 2304-2308 | 0.8 | 52 | Citations (PDF) |
| 173 | VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche | 30.7 | 3,123 | Citations (PDF) |
| 174 | Surveillance computed tomography after complete resection for non–small cell lung cancer: Results and costs | 2.2 | 28 | Citations (PDF) |
| 175 | Positron emission tomographic scanning in the diagnosis and staging of non–small cell lung cancer 2 cm in size or less | 2.2 | 51 | Citations (PDF) |
| 176 | Radical En Bloc Esophagectomy for Carcinoma of the Esophagus | 0.5 | 0 | Citations (PDF) |
| 177 | Bronchioloalveolar Carcinoma in Small Pulmonary Nodules: Clinical Relevance | 1.3 | 7 | Citations (PDF) |
| 178 | CT Screening for Lung Cancer: Past and Ongoing Studies | 1.3 | 35 | Citations (PDF) |
| 179 | En-bloc Esophagectomy—The Three-Field Dissection | 1.2 | 29 | Citations (PDF) |
| 180 | INVITED COMMENTARY | 2.6 | 0 | Citations (PDF) |
| 181 | Surgical Resection for Residual N2 Disease After Induction Chemotherapy | 2.6 | 41 | Citations (PDF) |
| 182 | Bronchioloalveolar Carcinoma and Ground Glass Opacities | 2.6 | 3 | Citations (PDF) |
| 183 | Cost Effectiveness of Chest Computed Tomography After Lung Cancer Resection: A Decision Analysis Model | 2.6 | 36 | Citations (PDF) |
| 184 | Intrathoracic Manifestations of Cervical Anastomotic Leaks After Transthoracic Esophagectomy for Carcinoma | 2.6 | 76 | Citations (PDF) |
| 185 | Imaging for Esophageal Tumors | 1.0 | 1 | Citations (PDF) |
| 186 | COX-2 inhibition in upper aerodigestive tract tumors | 2.8 | 66 | Citations (PDF) |
| 187 | Computerized Tomographic Nodule Heterogeneity: Present and Future Impact on Indications for Sublobar Resections | 2.1 | 47 | Citations (PDF) |
| 188 | Current state of imaging for lung cancer staging | 1.1 | 15 | Citations (PDF) |
| 189 | Imaging for esophageal tumors | 1.1 | 30 | Citations (PDF) |
| 190 | A simple solution for management of the postpneumonectomy empyema cavity | 2.6 | 2 | Citations (PDF) |
| 191 | Positron emission tomography scanning poorly predicts response to preoperative chemotherapy in non-small cell lung cancer | 2.6 | 100 | Citations (PDF) |
| 192 | COX-2: a target for prevention and treatment of esophageal cancer | 1.0 | 27 | Citations (PDF) |
| 193 | Managing the Small Pulmonary Nodule Discovered by CTChest, 2004, 125, 1522-1529 | 0.8 | 195 | Citations (PDF) |
| 194 | Stage IA Lung Cancer Size and Survival | 0.8 | 0 | Citations (PDF) |
| 195 | Surgical Resection for Lung Cancer in the OctogenarianChest, 2004, 126, 733-738 | 0.8 | 122 | Citations (PDF) |
| 196 | High Grade Dysplasia: Surveillance, Mucosal Ablation, or Resection? | 1.2 | 21 | Citations (PDF) |
| 197 | Preoperative chemotherapy for esophageal cancer with paclitaxel and carboplatin: results of a phase II trial | 2.2 | 27 | Citations (PDF) |
| 198 | David Bernt Skinner (1935-2003): a thoracic surgeon and something more**Title of presidential address given by D. B. Skinner, MD, to The American Association for Thoracic Surgery in April 1997. | 2.2 | 0 | Citations (PDF) |
| 199 | Thoracic esophageal perforations: a decade of experience | 2.6 | 143 | Citations (PDF) |
| 200 | Resection of a symptomatic pericardial cyst using the computer-enhanced Da Vinci™ surgical system | 2.6 | 27 | Citations (PDF) |
| 201 | Tumor Size Predicts Survival Within Stage IA Non-Small Cell Lung Cancer *Chest, 2003, 124, 1828-1833 | 0.8 | 160 | Citations (PDF) |
| 202 | The effects of platelet inhibitors on blood use in cardiac surgery | 1.0 | 20 | Citations (PDF) |
| 203 | Three-Field Lymph Node Dissection for Squamous Cell and Adenocarcinoma of the Esophagus | 3.4 | 390 | Citations (PDF) |
| 204 | Diagnosis and management of early lung cancer | 1.2 | 7 | Citations (PDF) |
| 205 | Ruptured descending and thoracoabdominal aortic aneurysms | 2.6 | 48 | Citations (PDF) |
| 206 | Early lung cancer detection and treatment strategies | 1.0 | 7 | Citations (PDF) |
| 207 | Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: Evidence for involvement of bile acids | 0.9 | 137 | Citations (PDF) |
| 208 | Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer | 16.1 | 493 | Citations (PDF) |
| 209 | Should En Bloc Esophagectomy Be the Standard of Care for Esophageal Carcinoma? | 3.4 | 202 | Citations (PDF) |
| 210 | Early Lung Cancer Action Project | 2.7 | 462 | Citations (PDF) |
| 211 | Immunohistochemical analysis of NY-ESO-1 antigen expression in normal and malignant human tissues | 2.8 | 322 | Citations (PDF) |
| 212 | Early Lung Cancer Action Project | 2.6 | 50 | Citations (PDF) |
| 213 | Inhibition of Cyclooxygenase‐2 | 2.6 | 52 | Citations (PDF) |
| 214 | Detection of early-stage lung cancer: Computed tomographic scan or chest radiograph? | 2.2 | 35 | Citations (PDF) |
| 215 | Early Lung Cancer Action Project: A Summary of the Findings on Baseline Screening | 2.5 | 136 | Citations (PDF) |
| 216 | Acidic fibroblast growth factor is expressed sequentially in the progression from Barrett's esophagus to esophageal adenocarcinoma | 0.6 | 1 | Citations (PDF) |
| 217 | Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer | 5.2 | 218 | Citations (PDF) |
| 218 | Long-term outcome after resection for bronchial carcinoid tumors✩ | 1.2 | 164 | Citations (PDF) |
| 219 | Expression of cancer-testis antigens in lung cancer: definition of bromodomain testis-specific gene (BRDT) as a new CT gene, CT9 | 6.5 | 122 | Citations (PDF) |
| 220 | Paraesophageal hernia repair | 0.2 | 0 | Citations (PDF) |
| 221 | STAGING AND THE SURGICAL MANAGEMENT OF LUNG CANCER | 1.0 | 39 | Citations (PDF) |
| 222 | Three-Field Lymphadenectomy for Esophageal Cancer | 1.4 | 5 | Citations (PDF) |
| 223 | The Rationale for Radical Resection | 0.8 | 13 | Citations (PDF) |
| 224 | Inhibition of Cyclooxygenase-2 Gene Expression by p53 | 1.3 | 299 | Citations (PDF) |
| 225 | Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells | 2.2 | 268 | Citations (PDF) |
| 226 | Invited Commentary | 1.2 | 0 | Citations (PDF) |
| 227 | Early Lung Cancer Action Project: overall design and findings from baseline screening | 46.9 | 2,472 | Citations (PDF) |
| 228 | Massive hiatal hernias: The anatomic basis of repair | 2.2 | 102 | Citations (PDF) |
| 229 | Ct-guided transthoracic needle biopsy following indeterminate fiberoptic bronchoscopy in solitary pulmonary nodules | 1.2 | 13 | Citations (PDF) |
| 230 | Cardiac Operations in Patients With Cirrhosis | 2.6 | 143 | Citations (PDF) |
| 231 | Outcome analysis of 245 CarboMedics and St. Jude valves implanted at the same institution | 2.6 | 29 | Citations (PDF) |
| 232 | Dihydroxy Bile Acids Activate the Transcription of Cyclooxygenase-2 | 1.3 | 181 | Citations (PDF) |
| 233 | CT-guided transthoracic needle biopsy of small solitary pulmonary nodules | 1.2 | 72 | Citations (PDF) |
| 234 | En bloc esophagectomy improves survival for stage III esophageal cancer | 2.2 | 145 | Citations (PDF) |
| 235 | Expression of acidic fibroblast growth factor in Barrett's esophagus and associated esophageal adenocarcinoma | 2.2 | 22 | Citations (PDF) |
| 236 | Occult cervical nodal metastasis in esophageal cancer: Preliminary results of three-field lymphadenectomy | 2.2 | 142 | Citations (PDF) |
| 237 | Epidemiology and molecular biology of Barrett's adenocarcinoma 1997, 13, 270-280 | | 69 | Citations (PDF) |
| 238 | Is Barrett's Esophagus the Precursor of Most Adenocarcinomas of the Esophagus and Cardia? A Biochemical Study | 3.4 | 49 | Citations (PDF) |
| 239 | PITFALLS AND COMPLICATIONS OF COLON INTERPOSITION | 1.4 | 1 | Citations (PDF) |
| 240 | Primary Inflammatory Fibrosarcoma of the Esophagus | 2.6 | 5 | Citations (PDF) |
| 241 | Endosonography for cancer of the esophagus and cardia: is it worthwhile? | 0.6 | 1 | Citations (PDF) |
| 242 | The mutational status of p53 protein in gastric and esophageal adenocarcinoma cell lines predicts sensitivity to chemotherapeutic agents | 2.8 | 88 | Citations (PDF) |
| 243 | Amplification of HER-2/neu gene in human gastric adenocarcinomas: correlation with primary site | 0.9 | 23 | Citations (PDF) |
| 244 | Defining the invasive phenotype of proximal gastric cancer cells | 2.7 | 32 | Citations (PDF) |
| 245 | Squamous cell carcinoma of the esophagus: Therapeutic dilemma | 1.2 | 9 | Citations (PDF) |
| 246 | Esophageal Carcinoma with Airway InvasionChest, 1994, 106, 742-745 | 0.8 | 38 | Citations (PDF) |
| 247 | ACHALASIA OF THE ESOPHAGUS | 1.4 | 0 | Citations (PDF) |
| 248 | Characterization of cell lines established from human gastric-esophageal adenocarcinomas: Biologic phenotype and invasion potential | 2.7 | 51 | Citations (PDF) |
| 249 | Endobronchial Spread of Bronchioloalveolar CarcinomaChest, 1993, 104, 951-953 | 0.8 | 19 | Citations (PDF) |
| 250 | Thoracic esophageal diverticula | 2.2 | 146 | Citations (PDF) |
| 251 | High-grade dysplasia in the columnar-lined esophagus | 1.2 | 199 | Citations (PDF) |
| 252 | Benign esophageal tumors | 0.6 | 2 | Citations (PDF) |
| 253 | Simultaneous Pulmonary and Renal Malignancy | 0.8 | 11 | Citations (PDF) |
| 254 | Infrequent point mutations of ras oncogenes in gastric cancers | 0.9 | 63 | Citations (PDF) |
| 255 | Reply | 2.6 | 0 | Citations (PDF) |
| 256 | Indications for esophagectomy in nonmalignant Barrett's esophagus: A 10-year experience | 2.6 | 28 | Citations (PDF) |
| 257 | Pathophysiology of gastroesophageal reflux | 1.4 | 22 | Citations (PDF) |
| 258 | Zenker’s diverticulum: clinical features and surgical management | 0.6 | 15 | Citations (PDF) |
| 259 | Pancreatic Biopsy | 1.2 | 28 | Citations (PDF) |
| 260 | The importance of lymph node dissection accompanying wedge resection for clinical stage IA lung cancer† | 1.2 | 30 | Citations (PDF) |
| 261 | Distinct Akt phosphorylation states are required for insulin regulated Glut4 and Glut1-mediated glucose uptake | 1.0 | 157 | Citations (PDF) |
| 262 | Lung cancer patients have the highest malignancy-associated suicide rate in USA: a population-based analysis | 0.9 | 61 | Citations (PDF) |
| 263 | Minimally Invasive Surgery for Lung Cancer Following Neoadjuvant Therapy in the United States | 0.7 | 2 | Citations (PDF) |
| 264 | Design and Creation of a Racially Diverse Lung Cancer Registry with Detailed Genomic and Environmental Annotation | 0.6 | 2 | Citations (PDF) |
| 265 | Journal of Thoracic Oncology 20th Anniversary Series Surgery | 1.5 | 0 | Citations (PDF) |
| 266 | An Improved Bayesian Pick‐the‐Winner (IBPW) Design for Randomized Phase II Clinical Trials | 1.1 | 0 | Citations (PDF) |
| 267 | CALGB 140503 and the shift to sublobar resection for small, peripheral, node-negative NSCLC: historical context, secondary analyses, and next steps | 1.7 | 0 | Citations (PDF) |
| 268 | RF83. Single-Port Robotic Oncologic Lung Resection: A Prospective Comparison Against the Standard Multiport Platform | 2.2 | 0 | Citations (PDF) |
| 269 | CV40. The Underrecognized Tracheoesophageal Interaction in Tracheobronchomalacia – A Case of Unexpected Resolution of Dysphagia after Surgical Tracheobronchoplasty | 2.2 | 0 | Citations (PDF) |
| 270 | Outcomes Based on Age in CALGB 140503 (Alliance): Lobar Versus Sublobar Resection for Peripheral Stage IA Non-small Cell Lung Cancer | 2.1 | 0 | Citations (PDF) |
| 271 | Role of Lung Marking in the Age of Sublobar Resection | 2.7 | 0 | Citations (PDF) |
